GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.2867
-0.0172 (-5.66%)
Jul 28, 2026, 10:33 AM EDT - Market open
GlucoTrack Employees
GlucoTrack had 15 employees as of December 31, 2025. The number of employees increased by 4 or 36.36% compared to the previous year.
Employees
15
Change (1Y)
4
Growth (1Y)
36.36%
Revenue / Employee
n/a
Profits / Employee
-$1,125,933
Market Cap
1.79M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 15 | 4 | 36.36% | 15 | 0 |
| Dec 31, 2024 | 11 | 5 | 83.33% | 11 | 0 |
| Dec 31, 2023 | 6 | 3 | 100.00% | 6 | 0 |
| Dec 31, 2022 | 3 | -2 | -40.00% | 3 | 0 |
| Dec 31, 2021 | 5 | -6 | -54.55% | 5 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 339 |
| Jin Medical International | 273 |
| Retractable Technologies | 201 |
| Bionano Genomics | 97 |
| Femasys | 54 |
| Nephros | 36 |
| NEXGEL | 19 |
| Milestone Scientific | 15 |
GCTK News
- 10 days ago - E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing - GlobeNewsWire
- 11 days ago - Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives - GlobeNewsWire
- 11 days ago - GlucoTrack Proxy statement: Proxy filing - Filings
- 11 days ago - UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform - GlobeNewsWire
- 13 days ago - Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform - GlobeNewsWire
- 20 days ago - GlucoTrack announces USPTO notice of allowance for patent application - TheFly
- 20 days ago - Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform - GlobeNewsWire
- 5 weeks ago - GlucoTrack Proxy statement: Proxy filing - Filings